Digital Building and training AI models for pharmacovigilance There’s no escaping the rise of AI adoption and integration. It’s not so much a question of whether you will adopt AI into your business practices, but how.
R&D The 3 biggest mistakes we keep making in clinical operations The life sciences industry is notoriously slow to change – for good reason, as there’s significantly more at stake than in other industries.
R&D Now is the time for pharma to help solve bias in clinical tr... Pharma has a great opportunity ahead of it when it comes to conducting representative clinical trials.
News Chiesi signs $1.9bn deal to buy KalVista and its HAE drug Chiesi has boosted its rare disease business with an agreement to buy KalVista and Ekterly, its oral drug for treating attacks in rare disease HAE.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.